Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP909680.RAfp238Gnl2wwzenPVaE97t7W7Z7DI6n5d33jdRC3C5nM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP909680.RAfp238Gnl2wwzenPVaE97t7W7Z7DI6n5d33jdRC3C5nM130_assertion type Assertion NP909680.RAfp238Gnl2wwzenPVaE97t7W7Z7DI6n5d33jdRC3C5nM130_head.
- NP909680.RAfp238Gnl2wwzenPVaE97t7W7Z7DI6n5d33jdRC3C5nM130_assertion description "[The TLR9-mediated activation of the vertebrate immune system suggests using such TLR9 agonists as effective vaccine adjuvants for infectious disease, and for the treatment of cancer and asthma/allergy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP909680.RAfp238Gnl2wwzenPVaE97t7W7Z7DI6n5d33jdRC3C5nM130_provenance.
- NP909680.RAfp238Gnl2wwzenPVaE97t7W7Z7DI6n5d33jdRC3C5nM130_assertion evidence source_evidence_literature NP909680.RAfp238Gnl2wwzenPVaE97t7W7Z7DI6n5d33jdRC3C5nM130_provenance.
- NP909680.RAfp238Gnl2wwzenPVaE97t7W7Z7DI6n5d33jdRC3C5nM130_assertion SIO_000772 18020622 NP909680.RAfp238Gnl2wwzenPVaE97t7W7Z7DI6n5d33jdRC3C5nM130_provenance.
- NP909680.RAfp238Gnl2wwzenPVaE97t7W7Z7DI6n5d33jdRC3C5nM130_assertion wasDerivedFrom befree-20150227 NP909680.RAfp238Gnl2wwzenPVaE97t7W7Z7DI6n5d33jdRC3C5nM130_provenance.
- NP909680.RAfp238Gnl2wwzenPVaE97t7W7Z7DI6n5d33jdRC3C5nM130_assertion wasGeneratedBy ECO_0000203 NP909680.RAfp238Gnl2wwzenPVaE97t7W7Z7DI6n5d33jdRC3C5nM130_provenance.